Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
GLP-1 barriers begin to break down
Becker's Healthcare December 12, 2024
Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.
In December, Eli Lilly partnered with telehealth company Ro, enabling eligible patients to receive Zepbound prescriptions during telehealth visits and have the medication shipped directly to their homes. This initiative is integrated with LillyDirect, the company’s direct-to-consumer platform, which offers patients the option to pay out of pocket for Zepbound. Single-dose vials of the drug are available at $399 for a 2.5-milligram vial and $549 for a 5-milligram vial, both covering a four-week supply.
The label for Zepbound also underwent a significant change this fall, broadening its accessibility. Previously, the label specified...
Today's Sponsors
Today's Sponsor